The Europe Omega 3 Supplements Market would witness market growth of 8.3% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Omega 3 Supplements Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $872.8 million by 2031. UK market is exhibiting a CAGR of 7.4% during (2024 - 2031). Additionally, The France market would experience a CAGR of 9.1% during (2024 - 2031).
The growth of the market reflects broader societal trends, such as the increasing prioritization of wellness, the rise of personalized nutrition, and a growing emphasis on sustainability. Valued at billions of dollars globally, the market encompasses diverse products, from traditional fish oil capsules to plant-based alternatives derived from algae and seeds. This diversity caters to varying dietary needs, including vegetarians, vegans, and individuals with fish allergies.
Moreover, according to recent statistics, the number of vegans in South Africa has doubled in the past five years alone, with an estimated 1% of the population identifying as vegans. Also, as per the U.S. Department of Agriculture, Germany has the highest rate of vegetarianism compared to its European neighbours, and the number of vegans reached over 1.5 million people in 2022.
Europe is witnessing steady growth, driven by increasing health concerns and a growing focus on preventive healthcare. The rising prevalence of neurological disorders and the significant burden of respiratory diseases across the European Union (EU) are key factors fuelling the demand for Omega-3 supplements. With mounting scientific evidence supporting the role of Omega-3 fatty acids in brain health and inflammation reduction, European consumers are increasingly incorporating these supplements into their daily routines. As awareness grows and healthcare systems emphasize disease prevention, the market in Europe is poised for expansion.
Free Valuable Insights: The Global Omega 3 Supplements Market will Hit USD 12.91 Billion by 2031, at a CAGR of 8.6%
Based on Functionality, the market is segmented into Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, and Other Functionality. Based on End Use, the market is segmented into Adults, Geriatric, Pregnant Women, Children, and Infants. Based on Source, the market is segmented into Fish Oil, Algae Oil, Krill Oil, and Other Source. Based on Distribution Channel, the market is segmented into Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Prescribed, and Other Distribution Channel. Based on Form, the market is segmented into Soft Gels, Capsules, Tablets, and Other Form. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
By Functionality
By End Use
By Source
By Distribution Channel
By Form
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 